PUMA BIOTECHNOLOGY INC shareholders Q3 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
US BANCORP \DE\ 200$5260.00%
FRANKLIN RESOURCES INC 19,162$50,3960.00%
Tower Research Capital LLC (TRC) 4,431$11,6530.00%
WELLS FARGO & COMPANY/MN 295$7760.00%
NORTHERN TRUST CORP 69,452$182,6590.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 425,515$1,119,3800.00%
STATE STREET CORP 162,482$427,3280.00%
MILLENNIUM MANAGEMENT LLC 200,000$526,0000.00%
CITIGROUP INC 99,767$262,3870.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 19,453$51,1610.00%
GOLDMAN SACHS GROUP INC 84,144$221,2990.00%
MORGAN STANLEY 338,821$891,1000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 67,700$178,0510.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 40,200$105,7260.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 98,022$257,7980.00%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q3 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.